BIMO Considering Random Sampling Of Clinical Investigator Audits
This article was originally published in The Gray Sheet
Executive Summary
FDA's Bioresearch Monitoring division is considering the random sampling of clinical investigator inspections in the future, according to staffers at the Center for Devices and Radiological Health.
You may also be interested in...
BIMO Early Intervention Pilot Results To Be Shared In Industry “Report Card”
CDRH's Bioresearch Monitoring Division plans to begin a clinical investigator probability sampling project this summer to boost device application quality and human subject protections through earlier BIMO intervention
BIMO Early Intervention Pilot Results To Be Shared In Industry “Report Card”
CDRH's Bioresearch Monitoring Division plans to begin a clinical investigator probability sampling project this summer to boost device application quality and human subject protections through earlier BIMO intervention
CDRH Eyes Hospital Reuse After Completing Low-Risk Device Inspection Pilot
The Center for Devices & Radiological Health is considering a "special emphasis" project focusing on hospital reuse during fiscal year 2003
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: